Research that Identifies
Undiscovered Value in the MicroCap Market


Trxade Group Email List: Click to Subscribe

View Company Website: Click to View

Market Data: Yahoo Finance, SEC Filings, Bloomberg

Report Link: Updated Research Report (Dated 11/02/2020)

Symbol: MEDS
Analyst: Howard Halpern
Taglich Rating: Speculative Buy
Price Target: $9.50
Time Horizon: 12 Months
Rating Established: June 10, 2020
Price When Established: $6.12
Most Recent Report: November 2, 2020
Price When Issued: $4.18

What's New

Trxade Launches MedChecks Subsidiary

On February 9, 2021, Trxade Group, Inc. announced the launch of its MedCheks subsidiary. MedCheks, led by James Ram will work to bring a digital health passport the marketplace.

The subsidiary's offering, once launched should allow a holder to display vaccination status and test results for travel or access to events and public facility. The digital health passport offering should leverage both state-of-the-art encryption and blockchain technology to conceal all private health data that allows for the secure exchange of data between a passport holder and verifier.

The leader of this effort is James Ram who comes to MedChecks with over 25 years of experience in the travel, tourism, and location-based entertainment industry. Prior to joining the company, he founded Indusa Global, a specialized information systems firm for the tourism and national security industry.

Trxade Announces Strategic Telehealth Partnership with KPH Healthcare Services

On December 10, 2020, Trxade Group, Inc. announced a strategic telehealth partnership with KPH Healthcare Services. KPH is a leading pharmaceutical and healthcare services provider.

The agreement call for Bonum Health to provide affordable telemedicine services to two divisions of KPH Healthcare Services, Inc., the patients of approximately 100 Kinney Drug retail pharmacies in New York and Vermont, as well as more than two million Rx discount card members of Kinney’s sister company, ProAct, Inc., a fully integrated pharmacy benefits manager with a wholly owned mail order pharmacy.

Company Description

Trxade Group Inc., headquartered in Tampa, Florida, is an integrated technology and services company focused on delivering an effective process for purchasing and delivering prescription drugs to independent pharmacies and consumers in the US. MEDS is developing a complete platform to make healthcare services affordable and accessible in the US through the integration of its existing Web-based trading platform, a licensed wholesaler, and its mobile telehealth service through the Bonum Health app and delivery capabilities. The company is developing the ability to provide healthcare services to patients without the patient leaving their home.

Company Reports

Updated Research Report (Dated 11/02/2020)
Updated Research Report (Dated 07/30/2020)
Initial Research Report (Dated 06/10/2020)


Please view our current disclosure and disclaimer on our most recent research report.